IA
OLMA icon

IFP Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

IFP Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89 Hold
6
– – ﹤0.01% 4755
2025
Q4 		$150 Hold
6
– – ﹤0.01% 4522
2025
Q3 		$59 Buy
+6
New +$36 ﹤0.01% 4633
2025
Q2 		– Hold
0
– – – 3909
2025
Q1 		– Hold
0
– – – 4202
2024
Q4 		– Hold
0
– – – 4434

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

IFP Advisors's OLMA Position: Q1 2026 in Review

IFP Advisors held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 6 shares worth $89. The position accounts for ﹤0.01% of the portfolio, ranked #4755.

IFP Advisors first reported a position in OLMA in Q3 2025 and has held it in 3 quarters since. The position peaked at $150 in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • IFP Advisors held 6 shares of Olema Pharmaceuticals worth $89 as of Q1 2026.
  • IFP Advisors left its Olema Pharmaceuticals share count unchanged in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4755 holding.
  • IFP Advisors first reported a position in Olema Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • IFP Advisors's Olema Pharmaceuticals position peaked at $150 in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.